Lifeist Terminates Agreement for Sale of Australian Vapes

$FLGC
Biotechnology: Pharmaceutical Preparations
Health Care
Get the next $FLGC alert in real time by email

TORONTO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness announces the termination of the share purchase agreement (the "SPA") entered into on September 17, 2023 with Flora Growth Corp. (NASDAQ:FLGC) ("Flora") to divest and sell Australian Vaporizers Pty Limited ("Australian Vapes"), its wholly owned Australian subsidiary, to Flora. The transaction and its details were previously disclosed in a news release dated September 18, 2023, a copy of which can be found on SEDAR+ under the Company's profile. The SPA was terminated, in accordance with its terms, effective October 20, 2023, the agreed-upon closing date for the completion of the transaction, as a result of a certain condition precedent which must be fulfilled at or before the closing not being fulfilled, thereby allowing either party to terminate the SPA, which the Company was obligated to do in the circumstances.

"While we weren't able to proceed with this particular transaction, we continue to explore opportunities that will enhance our position as a leader in the wellness market," said Meni Morim, CEO of Lifeist. "In parallel we will continue to operate Australian Vaporizers and accelerate plans to increase its growth."

Lifeist remains dedicated to its mission of delivering wellness solutions and will continue to pursue opportunities that drive its long-term vision forward.

About Lifeist Wellness Inc. 

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products; Australian Vapes, one of Australia's largest online retailers of vaporizers and accessories; and Mikra, a biosciences and consumer wellness company developing and selling innovative therapies for cellular health.  

Information on Lifeist and its businesses can be accessed through the links below:  

www.lifeist.com  

https://cannmart.com  

https://www.roilty.co  

https://wearemikra.com/  

www.australianvaporizers.com.au  

  

Contact:  

Meni Morim 

CEO 

Lifeist Wellness Inc. 

Ph: 647-362-0390  

Email: ir@lifeist.com  

  

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.  

Source: Lifeist Wellness Inc.  



Primary Logo

Get the next $FLGC alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$FLGC

DatePrice TargetRatingAnalyst
11/25/2024$4.00Buy
Aegis Capital
10/13/2021$10.00Buy
Roth Capital
6/23/2021$6.00Buy
MKM Partners
More analyst ratings

$FLGC
Press Releases

Fastest customizable press release news feed in the world

See more
  • Flora Growth Corp. Closes Acquisition of Australian Vaporizers

    Fort Lauderdale, Florida--(Newsfile Corp. - June 5, 2024) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company") has entered into a share purchase agreement (the "Agreement") to acquire of all of the issued and outstanding shares of Australian Vaporizers Pty Limited ("Australian Vaporizers") in exchange for 550,000 Flora common shares, valued at $0.7 million based on the closing price of Flora's common shares on June 3, 2024, subject to working capital adjustments. The transaction closed on June 4, 2024. Australian Vaporizers was founded in 2010 and has become one of the largest online retailers of vaporizers, hardware, and accessories in Australia. It is an online expert for aromathe

    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Lifeist Sells Australian Vapes

    TORONTO, June 05, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced the sale of Australian Vaporizers Pty Ltd. ("Aussie Vapes"), its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:FLGC) ("Flora"), a U.S.-based consumer-packaged goods and pharmaceutical distributor serving all 50 states and 28 countries. The sale was completed through a share purchase agreement (the "SPA") entered into between Lifeist, as vendor, and Flora Growth Corp, as purchaser, purs

    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • TSX Venture Exchange Stock Maintenance Bulletins

    VANCOUVER, BC, June 4, 2024 /CNW/ - TSX VENTURE COMPANIES BULLETIN V2024-1678 CEAPRO INC. ("CZO")BULLETIN TYPE: Plan of Arrangement, Remain Halted, DelistBULLETIN DATE: June 4, 2024TSX Venture Tier 2 Company  TSX Venture Exchange (the "Exchange") has accepted for filing documentation in connection with an arrangement agreement dated December 14, 2023, as amended on January 16, 2024, between Ceapro Inc. ("Ceapro") and Aeterna Zentaris Inc. ("Aeterna"), pursuant to which Aeterna acquired all of the issued and outstanding common shares of Ceapro by way of a plan of arrangement under the Canada Business Corporations Act (the "Arrangement"). Under the terms of the Arrangement, Ceapro shareholder

    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

$FLGC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$FLGC
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$FLGC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$FLGC
SEC Filings

See more

$FLGC
Leadership Updates

Live Leadership Updates

See more
  • Flora Growth Corp. Appoints Clifford Starke as Chief Executive Officer and Dany Vaiman as Chief Financial Officer; Regains Compliance with NASDAQ Minimum Bid Requirement

    Fort Lauderdale, Florida--(Newsfile Corp. - June 27, 2023) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries, announced today that Clifford Starke has been appointed as Chief Executive Officer to lead its global operations and Dany Vaiman has been appointed as Chief Financial Officer. Mr. Starke, who previously served as President of the Company, takes over for Hussein Rakine, who resigned as CEO but will remain on the Company's Board of Directors. Mr. Rakine expressed his confidence in the appointment, stating, "Clifford's

    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of Directors

    Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company") a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors (the "Board") accepted the resignation of Luis Merchan as Chairman of the Board and the Company's Chief Executive Officer (CEO). To fill the vacancies created by Mr. Merchan's resignation, the Board has appointed JustCBD founder, Hussein Rakine, as CEO and member of the board of directors. Of the appointment, former-Chairman and CEO, Luis Merchan said, "At Flora we have consistently placed human capital as a critical part of our M&A strategy. That's why today we are honored to have the former foun

    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • CBD Oil Market to Hit Nearly US$137 Billion by 2029

    FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Aug. 23, 2022 /PRNewswire/ -- The CBD oil market is expected to witness an astounding CAGR of 38.90% from 2021 until 2029, climbing from $9.86 billion to $136.64 billion. There are several reasons behind the projected growth such a growing number of CBD-infused skincare products, increased use of THC and CBD in pain management and treatment, rising sales in both retail stores and online, expanding research, and increasing demand for ingestible products. Governments around the world have also begun opening up more doors for CBD, with a recent Health Canada report suggesting legal framework to broaden retail CBD sales across

    $CGC
    $CRON
    $FLGC
    $OGI
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations

$FLGC
Financials

Live finance-specific insights

See more
  • Flora Growth Sets Third Quarter 2022 Conference Call for November 28, 2022, at 4:30 P.M. ET

    Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its third quarter 2022 earnings call via webcast on Monday, November 28 at 4:30 p.m. ET. During the webcast, Flora management will deliver financial and operational results for the third quarter ended September 30, 2022, and provide updates on Flora's commercial wholesale operations, house of brands and life sciences division strategies. Following the webcast, Flora management will open the call to analysts, media and investors in a Q&A format. Live Webcast Details Date: Monday, November 28, 2022 Time: 4:30 p.m. ET

    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Flora Growth to Host Webcast Discussing M&A Activity and International Market Opportunities - Wednesday, October 26, 2022

    Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that the Company will be hosting an analyst call on Wednesday, October 26, 2022, at 02:00 p.m. EST via webcast to discuss Flora Growth's recent M&A activity and strategic growth opportunities. The conference call and live webcast will invite analysts to pose questions to Flora and Franchise Global Health's leadership teams regarding the recent announcement of the definitive agreement of acquisition between the two companies and the opportunities within the cannabis industry on the global stage. To access this ca

    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Flora Growth Awarded Best M&A Deal at Benzinga Cannabis Capital Conference

    Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that the Company received the Best M&A Deal award at Benzinga's 2022 Cannabis Capital Conference in Chicago. "We are honored to receive the award for Best M&A Deal at the Benzinga Cannabis Capital Conference, which recognizes our strategic M&A objectives including acquiring products, expertise, expanding distribution, and customers," said Luis Merchan, Chairman and CEO of Flora. Flora completed the acquisition of JustCBD in February 2022, and it immediately offered the Company an established CPG brand with a por

    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

$FLGC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more